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Nonsurgical recanalization of the occluded coronary ar-
tery has been performed in patients with evolving myo-
cardial infarction since the late 1970s by intracoronary
administration of thrombolytic agents at the ostium of
the occluded artery or directly to the site of occlusion.
The authors review the basic concepts underlying intra-
coronary thrombolysis, the method applied at their in-
stitution and the clinical results. Reperfusion of totally
occluded arteries or termination of the ischemicstate in
subtotally occluded arteries was achieved in 71 (87.7%)
of 81 patients. Reocclusion occurred in four patients, in
three of these at a time when anticoagulation became
temporarily ineffective, emphasizing the need for un-
interrupted anticoagulation with a partial thromboplas-
Extensive myocardial necrosis remains the principal cause
of in-hospital mortality and morbidity among patients with
acute myocardial infarction by provoking heart failure (1),
myocardial rupture (2) and lethal arrhythmias (3). Inter-
ventions designed to limit ischemic necrosis (4) appeared
effective in animal experiments of relatively short duration,
but in patients the application and evaluation of some of
these interventions proved less than satisfactory. Recent
investigations (5,6) seem to shed light on this discrepancy.
They suggest that only restoration of blood flow can reduce
necrosis, whereas reduction in myocardial oxygen demand
and other interventions not providing substantial increases
in coronary perfusion can slow the rate of necrosis, but
cannot significantly reduce the ultimate size of the infarct.
Hence, it has become apparent that clinically meaningful
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tin time longer than 80 seconds. Thallium scintigraphic
studies before and after reperfusion showed a decrease
in defect, indicating myocardial salvage, in the successful
cases but not in failures or untreated control subjects.
A decrease in thallium-201 defect was followed by im-
provement of regional wall motion and usually also left
ventricular ejection fraction. Three of the patients with
an unsuccessful result and one patient with a successful
result died. Bypass surgery was performed electively in
18 patients because of multiple vessel involvement. In-
tracoronary thrombolysis appears to be a relatively safe
and promising procedure. A large controlled study will
be needed for definitive assessment of its role in the
management of acute myocardial infarction.
limitation of myocardial necrosis in patients with evolving
myocardial infarction would require early restoration of blood
flow to the jeopardized ischemic myocardium.
Time Limits of Effective Reperfusion
In dogs, myocardial necrosis may begin after only 20
minutes of coronary artery occlusion (7), originating in the
subendocardium and progressing in a wave front toward the
epicardium (8). Within 6 hours the necrosis is usually com-
plete (7,9). In monkeys, the rate of necrosis was found to
be similar (10). In human beings, the rapidity of necrosis
is influenced by the completeness of arterial occlusion, the
presence of acquired collateral circulation and hemodynamic
and metabolic factors affecting coronary blood flow and
myocardial oxygen demand. Wall motion studies (11) and
serial thallium-20l scintigrams (unpublished observations)
suggest that in patients in whom occlusion of the coronary
artery is complete and collateral vessels are not demonstra-
ble radiologically, significant myocardial salvage is unlikely
after more than 4 to 5 hours of permanent coronary artery
occlusion. In patients with incomplete or intermittent oc-
clusion of the coronary artery or with significant visible
collateral circulation, myocardial salvage is possible for
considerably longer than 5 hours after the onset of pain (12).
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In the early stage of coronary artery occlusion, the elec-
trocardiogram is not helpful in determining whether and how
much of the ischemic myocardial injury is still reversible
because the electrocardiographic signs of necrosis-namely,
abnormal Q waves and diminution of R waves-usually lag
many hours behind the structural necrosis (13, 14). Simi-
larly, serum creatine kinase (CK) activity increases to diag-
nostically abnormal levels usually late, approximately 6 to
8 hours after the clinical signs of coronary occlusion, at a
time when necrosis can be expected to be complete in most
patients (15,16).
Thrombosis: The Mechanism of Coronary
Artery Occlusion
Autopsy studies of recent years (17-25) found an 85 to
95% frequency of thrombotic coronary artery occlusion in
patients dying of acute transmural myocardial infarction. In
vivo angiography (26) and retrieval of thrombi by the sur-
geon in patients with acute myocardial infarction (27) con-
firmed the high frequency of thrombotic occlusion.
Intravenous Thrombolysis in Acute
Myocardial Infarction
Streptokinase or urokinase has been administered intra-
venously to patients with acute myocardial infarction in
multicenter trials designed with the assumption that throm-
bosis is the cause of coronary artery occlusion. Treatment
was initiated late, up to 72 hours after the onset of infarction
symptoms. Mortality was used as the only end point; mark-
ers of coronary reperfusion were not analyzed. These trials
(28) failed to show a reduction in mortality with the ex-
ception of a recent study (29).
The success of intracoronary thrombolysis has stimulated
a reassessment of the intravenous route. Streptokinase is
now administered during the first few hours of an evolving
infarction in doses of 500,000 to 1,500,000 IV over 20 to
60 minutes. The initial studies (30) appear encouraging in
that they report a reperfusion rate higher than 50%.
Intracoronary Thrombolysis
Pilot studies (31,32) with intracoronary thrombolysis were
soon followed by a number of more comprehensive reports
(12,33-41). The procedures used in these studies varied
widely in the time limit for patient inclusion, the mode of
administration and dosage of the thrombolytic agent and the
methods used to prevent rethrombosis. We will outline our
approach and clinical experience and correlate these with
the reports of others when appropriate.
Patient selection. Patients with evolving myocardial in-
farction likely to benefit from reperfusion are considered
suitable candidates for intracoronary thrombolysis. In the
absence of satisfactory markers of reversible myocardial
injury and taking into account the rapidity of necrosis, the
logistic delay and the time interval needed for angiography
and thrombolysis itself (about 45 to 50 minutes), we set 3
hours from the onset of pain as the time limit for patient
acceptance. Persistent pain unrelieved by 0.3 mg of sublin-
gual nitroglycerin and accompanied by ST segment eleva-
tions and reciprocal ST segment depressions in the electro-
cardiogram are the inclusion criteria for acceptance. There
must also be no contraindication to thrombolysis, anticoa-
gulation or angiography.
There were 81 patients, 64 men and 17 women. The age
of the patients ranged from 31 to 80 years (average 54.3).
The left anterior descending coronary artery was the site of
acute occlusion in 38%, the right coronary artery in 45%
and the left circumflex artery in 17% of patients.
Methods of coronary catheterization and streptoki-
nase infusion. In the catheterization laboratory, an in-
dwelling Longdwell Teflon needle is placed in the left radial
or femoral artery for monitoring of arterial pressure and
sampling of blood. An 8F regular or 7F "high flow" Judkins
catheter is introduced into the right femoral artery. A 5,000
IV bolus of heparin is administered intravenously as soon
as the femoral artery is entered. In patients with anterior
infarction, the left coronary artery is visualized first. In
patients with inferior infarction, the right coronary artery is
visualized first because, in our experience, it is two to three
times more likely to be the cause of inferior infarction than
the circumflex artery. When occlusion of the coronary artery
is confirmed, 2,500 to 5,000 IV of heparin is added. Intra-
coronary nitroglycerin is no longer administered, because
it proved ineffective in our first 40 patients.
For infusion of the thrombolytic agent, a special 2Y2F
catheter (coronary infusion catheter, American Edwards
Laboratories) is inserted through the straight arm of a Y-
shaped side arm adaptor (Cook side arm adaptor) into the
Judkins catheter and positioned 2 to 3 mm proximal to the
site of occlusion. To avoid damage to the coronary intima,
the distal 20 em of the infusion catheter is made very soft
and flexible and reduced to 2F size. The tip of the catheter
is intensely radiopaque to allow precise placement of the
catheter within the coronary artery. After placement, the
catheter is stretched slightly to eliminate any redundancy
that would allow the catheter to float into or beyond the
partially lysed clot. Proper placement of the catheter is con-
firmed in at least two angiographic views. The oblique arm
of the Y adaptor is used for monitoring intracoronary pres-
sure and for intermittent injections of contrast medium. Dur-
ing administration of the thrombolytic agent, the angi-
ography catheter remains in the ostium of the coronary artery.
Special infusion catheters, preshaped to enter subselectively
either the left anterior descending or the circumflex branch,
are used for the left coronary artery.
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In the first 40 patients, thrombolysin (a 1:2 mixture of
streptokinase and plasmin) was injected into the occluded
artery at initial rates of 4,000 to 6,000 IU/min in 2 to 3 ml
of 5% dextrose solution per minute. Currently, streptokinase
is administered at a rate of 2,000 IU in 2 ml of saline solution
per minute. After achieving patency, the infusion is con-
tinued for at least I hour. The purpose of the protracted
infusion is to clear the clot completely from the coronary
artery and prevent rethrombosis. The cineangiographic film
is reviewed before the procedure is terminated. Morphine,
lidocaine, dopamine, aramine and atropine are given when
needed.
After completion of streptokinase administration, an in-
fusion of heparin is begun at a rate of 15 IV/kg per hour
and adjusted to maintain the partial thromboplastin time
(PTT) above 80 seconds, without allowing it to decrease to
nontherapeutic levels at any time, even for short periods.
In the case of surgery, the heparin infusion is continued
until the operation. If restudy is needed, angiography is
performed without interrupting the infusion of heparin. After
5 days, oral warfarin is substituted for heparin in doses
sufficient to keep the prothrombin time above twice control
values. Warfarin therapy is maintained for 3 months on the
assumption that, by then, the defect in the intima will heal
and become nonthrombogenic.
Results
Effect of contrast injection. After injection of the con-
trast medium alone, a small stream of flow appeared in
previously completely occluded arteries of four patients, an
observation also reported by Mathey et al. (35). The effect
of contrast injection is probably due to the mechanical force
of injection or to the hyperosmolality of the contrast me-
dium, causing dehydration and shrinkage of clot.
Effect of intracoronary thrombolysis. Intracoronary
infusion of the thrombolytic agent was commenced 206 ±
58 (± standard deviation) minutes after the onset of pain.
The infusion resulted in reopening of the completely oc-
cluded coronary artery in 64 of 74 patients and enlargement
of the lumen or termination of myocardial ischemia, or both,
in seven patients with subtotal occlusion. In 6 of the 10
patients, failure to open the artery may have been related
to nonselective injection of the thrombolytic agent. Patency
was achieved after 5 to 40 minutes of infusion (average 25.3
± 12.4).
Reperfusion of the completely occluded artery was sig-
naled by ventricular arrhythmias such as late premature ven-
tricular complexes occurring on or after the P wave (13
patients), bigeminy (6 patients), accelerated idioventricular
rhythm (13 patients), ventricular tachycardia (4 patients),
ventricular fibrillation (1 patient), disappearance of atrio-
ventricular or intraventricular block of recent origin (6 pa-
tients), transient increase in the severity of chest pain (22
patients) and bradycardia and nausea (12 patients). Reper-
fusion was followed by gradual relief of pain over a 10 to
15 minute period and gradual return of the ST segments
toward the isoelectric line, usually over a period of 1 to 2
hours. In three patients, the electrocardiogram returned to
normal; in the remaining patients, abnormal Q waves evolved,
indicating that some myocardial necrosis had been incurred
by the time of reperfusion.
Residual coronary artery stenosis. In about 80% of
the patients, the lumen size observed at the time of reper-
fusion had increased by the end of streptokinase infusion.
In nine patients, the residual diameter stenosis was found
to be less than 50%; in the remaining patients, the stenosis
ranged from 60 to 80%. Seven patients were restudied by
angiography before discharge; in four, the residual stenosis
was less severe at the time of the second study. The increase
in lumen size may be due to continued thrombolysis or
shrinkage of the ulcerated plaque, a phenomenon also ob-
served after angioplasty (42).
Reocclusion. Four patients with a successfully reopened
coronary artery developed chest pain and ST segment ele-
vations before hospital discharge; reocclusion of the coro-
nary artery was confirmed by angiography. In three of these
patients, the anticoagulation was found to be inadequate at
the time of reocclusion, in that the partial thromboplastin
time levels were in the normal range. The cause of inade-
quate anticoagulation in these patients was lowering of the
dose of heparin or its temporary discontinuation. The im-
portance of uninterrupted and effective anticoagulation ther-
apy was also underlined by occurrence of brief anginal ep-
isodes in three additional patients at the time when
anticoagulation became transiently ineffective. Figure I il-
lustrates the temporal association of chest pain and inad-
equate anticoagulation. Observations from other centers
(personal communication) that discontinuation of heparin
before bypass surgery or angiography can result in complete
reocclusion of the artery within 1 to 2 hours further em-
phasize the critical importance of uninterrupted protection
of the ulcerated plaque in the recently reopened coronary
artery. During subsequent follow-up periods (3 to 38 months),
only one patient developed signs of reocclusion 2 months
after successful thrombolysis; it is likely that anticoagulation
was inadequate at the time of reocclusion.
Changes in serum creatine kinase (CK) activity.
Before reperfusion, the serum CK and MB-CK activity
were within the normal range in virtually all our patients.
Usually within minutes of reperfusion, the activity began
to increase rapidly and reached a peak after 4 to 12 hours
(average 6.9). In four patients in whom flow in the reopened
coronary artery was sluggish, CK did not increase as long
as the flow remained sluggish. In the absence ofreperfusion,
abnormal CK levels were noted 6 to 8 hours after the onset
of pain, with a maximum at approximately 18 to 22 hours
(average 19.6). Paradoxically, because myocardial CK re-
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lease is perfusion-dependent, an increase in CK was ob-
served earlier in the presence of incomplete or intermittent
coronary occlusion although necrosis was less extensive
(43). The peak MB-CK ranged from 35 to 721 IV/liter
(average 170) in successfully reperfused patients and from
65 to 593 Il.l/liter (average 197) in patients whose artery
could not be reopened. The difference was not statistically
significant (probability [p] = 0.762). However, experi-
mental studies (44,45) and a recent clinical investigation
Figure 1. A, Temporal relation between coronary artery reocclu-
sion and inadequate anticoagulation. The patient had been in stable
condition for 5 days. On day 5, heparin was discontinued but
Coumadin therapy was not yet sufficiently effective (quick =
70%). Six hours later, the patient complained of severe chest pain
that was not relieved by sublingual nitroglycerin and was associated
with ST segment elevations in leads of initial involvement. The
angiogram confirmed reocclusion of the coronary artery. B, Tem-
poral relation between inadequate anticoagulation and the appear-
ance of rest angina. Rest angina on day I occurred when the partial
thromboplastin time (PTT) values had fallen to near control levels.
There was no recurrence of angina later when the partial throm-
boplastin time was maintained in the effective range.
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(46) suggest that CK release is substantially augmented by
reperfusion such that CK activity and CK release may be 2
to 3 times higher from the same amount of necrotic myo-
cardium afterreperfusion than in its absence. More complete
myocardial depletion of CK after reperfusion appears to be
the mechanism of increased CK release according to our
unpublished experimental data. Equality of the CK level in
the two groups, therefore, suggests that myocardial necrosis
may have been smaller by 50% or more in the reperfused
group than in patients in whom the artery was not reopened.
Salvage of jeopardized myocardium. The area of jeop-
ardized myocardium was delineated as a scintigraphic defect
by injecting thallium-201, 2 mCi intravenously, while the
coronary artery was still occluded. About I hour after re-
perfusion, a small dose of the isotope (30 /LCi) was injected
into the reopened coronary artery through the coronary in-
fusion catheter. Qualitative and computer-assisted quanti-
tative analysis showed significant, often dramatic reductions
Figure 2. A, The size and severity of the thallium scintigraphic
defect expressed in arbitrary units (U) and determined by a com-
puter-based technique were significantly smaller in 20 patients 10
days after successful reperfusion (ordinate) than before treatment
(abscissa). B, The size and severity of the thallium scintigraphic
defect remained generally unchanged in seven patients whose coro-
nary artery was not reopened. N = number of patients; p =
probability.
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Figure 3. Length of the akinetic segment on two-dimensional
echocardiogram. A, In eight patients, no significant change in
length of the akinetic segment was noted 3 hours after successful
reperfusion (ordinate) when compared with wall motion before
reperfusion (abscissa). B, In 15 patients, the length of the akinetic
segment was significantly smaller 10 days after successful reper-
fusion than before treatment. C, In 10 patients who did not undergo
thrombolysis, the length of the akinetic segment observed on day
10 was not different from the length measured at the time of
admission. NS = not significant; p = probabihty.
in scintigraphic defects in nearly all patients with successful
thrombolysis, but not in patients whose artery remained
closed (Fig. 2). Experimental studies in our laboratory (47)
confirmed that the lack of uptake of thallium-201 after in-
jection of the isotope into the reopened artery indicates
myocardial necrosis, whereas its uptake reflects myocardial
viability. The scintigram after reperfusion provided instant
information on the amount of salvaged viable myocardium,
important for decisions concerning angioplasty or bypass
surgery. Scintigrams obtained 10 to 12 days after an intra-
venous injection of 2 mCi of thallium-201 usually did not
differ significantly from these early postreperfusion scinti-
grams. Our findings are in agreement with reports from other
centers (36,41,48-50).
Changes in regional and global cardiac function. The
effect of reperfusion on regional wall motion abnormalities
was assessed with two-dimensional echocardiography. The
percent length of akinetic and dyskinetic myocardium was
determined in two perpendicular apical views before and 3
hours as well as 10 to 12 days after thrombolysis. In patients
with successful thrombolysis, the length of the abnormally
contracting myocardium was found to be significantly smaller
(by 40% on the average) in the late study, but no significant
improvement was observed 3 hours after thrombolysis. In
patients whose artery remained closed, the wall motion study
showed no improvement (Fig. 3).
Studies in our laboratory (51) have shown that the dys-
kinetic or akinetic but viable myocardium can contract force-
fully in response to inotropic stimulation after reperfusion,
but not while the artery remains occluded. This finding
explains why patients in cardiogenic shock survived follow-
ing successful thrombolysis, but not if the artery remained
closed (36).
Multiple gated blood pool scintigraphy was performed
approximately 3 hours after reperfusion and 10 days later.
In 43 patients in whom thrombolysis was successful and in
whom measurements were obtained on day 1 as well as day
10, the left ventricular ejection fraction increased from 44.9
± 9.5 to 50.1 ± 10.8% (p < 0.001). In 32 patients whose
artery remained closed or who did not undergo intracoronary
thrombolysis, there was no improvement in function (41.4
± 12.2 versus 43.4 ± 14.7; not significant). Significant
improvement in regional and global cardiac function after
successful reperfusion was also observed at other centers
(12,34,35,38,41).
Coronary bypass surgery. None of our patients re-
quired emergency surgery. Bypass surgery was performed
electively in 21 patients, usually 7 to 10 days after throm-
bolysis. Severe multiple vessel disease was the indication
for surgery in 17 patients, recurrent angina was the indi-
cation in 4. Two patients died 3 and 4 weeks, respectively,
after surgery. Both patients had previous infarcts and ex-
tensive recent necrosis. None of the remaining 19 patients
required circulatory support after surgery.
Mortality. Four of the 60 patients not operated on died.
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In three of these four, thrombolysis was either unsuccessful
or could not be carried out. The only patient dying in spite
of successful thrombolysis had had two prior infarcts and a
large chronic ventricular aneurysm, A large controlled study
will be necessary for quantitation of the effect of throm-
bolysis on mortality. Theoretically, reperfusion may reduce
mortality by several mechanisms: 1) by preserving a critical
myocardial mass; 2) by preventing transmural progression
of necrosis and thereby preventing myocardial rupture; and
3) by terminating myocardial ischemia and thereby the pos-
sibility of lethal ischemic arrhythmias.
Conclusions and Perspectives
Intracoronary thrombolysis appears to be an effective and
relatively safe method for reopening the coronary artery in
patients with acute myocardial infarction. The clinical im-
pact of successful reperfusion depends on how early after
coronary occlusion it is achieved. Myocardial salvage is
evidenced by reduction of thallium scintigraphic defects and
improvement of regional and global cardiac function. There
is suggestiveevidence that early reperfusion reduces mortality,
Large controlled studies are necessary for a definitive
assessment of the role of intracoronary thrombolysis in the
management of acute myocardial infarction.
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Marcus, MD, Avinash Mondkar, MD, and Thasana Nivatpumin, MD, and
the technical assistance of Lois Rodriguez, RN, and Wayne Fairchild.
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